Issuer: JPMorgan Chase Financial Company LLC, a direct,
wholly owned finance subsidiary of JPMorgan Chase & Co.
Guarantor: JPMorgan Chase & Co.
Index: The MerQube US Large-Cap Vol Advantage Index
(Bloomberg ticker: MQUSLVA). The level of the Index reflects a
deduction of 6.0% per annum that accrues daily.
Contingent Interest Payments: If the notes have not been
automatically called and the closing level of the Index on any
Review Date is greater than or equal to the Interest Barrier, you
will receive on the applicable Interest Payment Date for each
$1,000 principal amount note a Contingent Interest Payment
equal to at least $11.7917 (equivalent to a Contingent Interest
Rate of at least 14.15% per annum, payable at a rate of at least
1.17917% per month) (to be provided in the pricing
supplement).
If the closing level of the Index on any Review Date is less than
the Interest Barrier, no Contingent Interest Payment will be
made with respect to that Review Date.
Contingent Interest Rate: At least 14.15% per annum, payable
at a rate of at least 1.17917% per month (to be provided in the
pricing supplement)
Interest Barrier / Buffer Threshold: 70.00% of the Initial Value
Buffer Amount: 30.00%
Downside Leverage Factor: An amount equal to 1 / (1 - Buffer
Amount), which is 1.42857
Pricing Date: On or about March 10, 2026
Original Issue Date (Settlement Date): On or about March 13,
2026
Review Dates*: April 10, 2026, May 11, 2026, June 10, 2026,
July 10, 2026, August 10, 2026, September 10, 2026, October
12, 2026, November 10, 2026, December 10, 2026, January 11,
2027, February 10, 2027, March 10, 2027, April 12, 2027, May
10, 2027, June 10, 2027, July 12, 2027, August 10, 2027,
September 10, 2027, October 11, 2027, November 10, 2027,
December 10, 2027, January 10, 2028, February 10, 2028,
March 10, 2028, April 10, 2028, May 10, 2028, June 12, 2028,
July 10, 2028, August 10, 2028, September 11, 2028, October
10, 2028, November 10, 2028, December 11, 2028, January 10,
2029, February 12, 2029, March 12, 2029, April 10, 2029, May
10, 2029, June 11, 2029, July 10, 2029, August 10, 2029,
September 10, 2029, October 10, 2029, November 12, 2029,
December 10, 2029, January 10, 2030, February 11, 2030,
March 11, 2030, April 10, 2030, May 10, 2030, June 10, 2030,
July 10, 2030, August 12, 2030, September 10, 2030, October
10, 2030, November 11, 2030, December 10, 2030, January 10,
2031, February 10, 2031 and March 10, 2031 (final Review
Date)
Interest Payment Dates*: April 15, 2026, May 14, 2026, June
15, 2026, July 15, 2026, August 13, 2026, September 15, 2026,
October 15, 2026, November 16, 2026, December 15, 2026,
January 14, 2027, February 16, 2027, March 15, 2027, April 15,
2027, May 13, 2027, June 15, 2027, July 15, 2027, August 13,
2027, September 15, 2027, October 14, 2027, November 16,
2027, December 15, 2027, January 13, 2028, February 15,
2028, March 15, 2028, April 13, 2028, May 15, 2028, June 15,
2028, July 13, 2028, August 15, 2028, September 14, 2028,
October 13, 2028, November 15, 2028, December 14, 2028,
January 16, 2029, February 15, 2029, March 15, 2029, April 13,
2029, May 15, 2029, June 14, 2029, July 13, 2029, August 15,
2029, September 13, 2029, October 15, 2029, November 15,
2029, December 13, 2029, January 15, 2030, February 14,
2030, March 14, 2030, April 15, 2030, May 15, 2030, June 13,
2030, July 15, 2030, August 15, 2030, September 13, 2030,
October 16, 2030, November 14, 2030, December 13, 2030,
January 15, 2031, February 13, 2031 and the Maturity Date
Maturity Date*: March 13, 2031
Call Settlement Date*: If the notes are automatically called on
any Review Date (other than the first through fifth and final
Review Dates), the first Interest Payment Date immediately
following that Review Date
* Subject to postponement in the event of a market disruption event and
as described under "Supplemental Terms of the Notes -
Postponement of a Determination Date - Notes Linked Solely to an
Index" in the accompanying underlying supplement and "General Terms
of Notes - Postponement of a Payment Date" in the accompanying
product supplement